Medication info
Highset Tablet

Highset Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Kukje Pharmaceutical Co., Ltd.
Appearance
Pale yellow, rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200705994 · Notified 2007.05.25 · Insurance code 643702580

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is needed because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Older adults Use the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is needed because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
Kukje Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • chronic pain
View approved original text

This medication is used for the relief of acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is needed because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Older adults Use the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is needed because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medication can affect the liver, so individuals who regularly consume more than three servings of alcohol per day should consult a doctor or pharmacist before use. Additionally, serious skin reactions, such as severe rashes or pustules, may occur rarely; if skin rashes or hypersensitivity reactions are observed after taking this medication, use should be discontinued immediately. The tramadol component of this medication may increase the risk of seizures, especially if taken in larger than recommended amounts or in combination with certain antidepressants or narcotics. Severe allergic reactions may occur rarely, so symptoms like difficulty breathing or hives should be reported to medical personnel immediately. Patients with acute bronchial asthma may experience significant respiratory depression while taking this medication; therefore, it must be taken in a medically-equipped environment. This medication, when taken with alcohol or CNS depressants such as benzodiazepines, can cause severe drowsiness, respiratory depression, or even coma, so caution is required. Patients with head injuries or increased intracranial pressure should be cautious as symptoms may worsen with this medication. This medication can lead to psychological and physical dependence; therefore, prolonged use should be monitored closely for signs of dependency. Patients with liver dysfunction should consult a physician before taking this medication and should avoid taking other acetaminophen products simultaneously. Particularly, patients with the CYP2D6 enzyme that acts very quickly may excessively produce the active metabolite, leading to life-threatening respiratory depression, and should be cautious. Children under 12 years old and adolescents under 18 who have had tonsillectomy or adenoidectomy should not be administered this medication, especially if they have sleep apnea. Drowsiness or dizziness may occur after taking this medication; therefore, caution is advised when driving or operating machinery. Overdose can lead to serious respiratory depression, seizures, liver damage, etc., so the dosage must be strictly followed, and immediate medical attention should be sought in cases of emergency. This medication may interact with other drugs; therefore, individuals who are currently taking any medications should inform medical personnel, especially when taking MAO inhibitors, antidepressants, antibiotics, and CNS depressants concurrently. Women who are pregnant or breastfeeding should definitely consult a physician before taking this medication, and it is advisable not to administer it during breastfeeding due to potential risks to the baby. Elderly patients may have weakened liver, kidney, and heart functions and should exercise increased caution when using this medication. During the course of taking this medication, patients should discuss treatment goals and discontinuation plans thoroughly with their physician, and if signs of dependency or adverse reactions occur, they should seek immediate consultation.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylaxis, respiratory depression, deep sedation, coma, hepatotoxicity, hyponatremia, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, xerostomia, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, spatial disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory loss, tremor, paresthesia, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, seizures, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweats, urinary disorders, erectile dysfunction, asthenia, chest pain, emotional abnormality, chills, discomfort in the chest, lethargy, drug withdrawal syndrome, thirst, irritability, warmth sensation, weight loss, elevated serum creatinine, anaphylactic reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, emotional instability, delirium, suicidal ideation, muscle rigidity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, fixed rash, asthenia, fever, edema, rigidity, syncope, congestive heart failure, vertigo, confusion, exacerbation of migraine, involuntary muscle contractions, dyspnea, asthma, exercise-induced dyspnea, cough, bronchitis, urinary retention, frequency of urination, abnormal renal function values, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, loss of appetite, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, decreased platelets, arrhythmia, exacerbation of hypertension, aortic stenosis, gastrointestinal bleeding, increased cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nosebleed, abnormal vision, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, liver dysfunction, nausea, dizziness, paralytic ileus, cholecystitis, abnormal renal function values, increased salivation, gastrointestinal bleeding, nausea, dizziness, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, vomiting, dyspepsia, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, chest discomfort, withdrawal symptoms, anxiety, sweating, rigidity, pain, diarrhea, upper respiratory syndrome, trichotillomania, agitation, irritability, hyperactivity, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system response, toxic skin necrosis, bronchospasm

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air from entering and kept in a cool place at or below room temperature (25 degrees). Storing it this way will help maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Pale yellow, rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.